Review
doi: 10.1097/01.NAJ.0000403358.44058.f7.
Prevention and treatment of osteoporosis in postmenopausal women: a review
Affiliations
- PMID: 21795930
- DOI: 10.1097/01.NAJ.0000403358.44058.f7
Item in Clipboard
Review
Prevention and treatment of osteoporosis in postmenopausal women: a review
Am J Nurs.
2011 Aug.
Abstract
This article provides an overview of osteoporosis, describes current recommendations for its prevention and treatment, and discusses nursing implications. This is part two of a four-part series on postmenopausal health.
Comment in
-
Osteoporosis.Am J Nurs. 2011 Dec;111(12):12. doi: 10.1097/01.NAJ.0000408162.43747.9f. Am J Nurs. 2011. PMID: 22112867 No abstract available.
Similar articles
-
Seeking clarification of osteoporosis guidelines.CMAJ. 2004 Oct 26;171(9):1022; author reply 1022-3. doi: 10.1503/cmaj.1040991. CMAJ. 2004. PMID: 15505246 Free PMC article. No abstract available.
-
[Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention].MMW Fortschr Med. 2004 Aug 5;146(31-32):53. MMW Fortschr Med. 2004. PMID: 15529718 German. No abstract available.
-
Help your patient live with osteoporosis.Am J Nurs. 1999 Apr;99(4):55, 57-60. Am J Nurs. 1999. PMID: 10234326 No abstract available.
-
Postmenopausal osteoporosis: act now to prevent fracture.Adv Nurse Pract. 2005 Sep;13(9):41-4, 46, 59. Adv Nurse Pract. 2005. PMID: 16152816 Review. No abstract available.
-
Pharmacologic management of osteoporosis.J Hand Surg Am. 2013 Mar;38(3):588-92. doi: 10.1016/j.jhsa.2012.11.023. Epub 2013 Jan 9. J Hand Surg Am. 2013. PMID: 23312206 Review. No abstract available.
Cited by
-
Systematical Mutational Analysis of FRATtide against Osteoclast Differentiation by Alanine Scanning.ACS Med Chem Lett. 2024 Jul 10;15(8):1242-1249. doi: 10.1021/acsmedchemlett.4c00127. eCollection 2024 Aug 8. ACS Med Chem Lett. 2024. PMID: 39140067
-
Farnesyl Diphosphate Synthase Gene Associated with Loss of Bone Mass Density and Alendronate Treatment Failure in Patients with Primary Osteoporosis.Int J Mol Sci. 2024 May 22;25(11):5623. doi: 10.3390/ijms25115623. Int J Mol Sci. 2024. PMID: 38891810 Free PMC article.
-
Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways.Chin Med. 2024 May 14;19(1):69. doi: 10.1186/s13020-024-00938-6. Chin Med. 2024. PMID: 38745234 Free PMC article.
-
A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species.Oxid Med Cell Longev. 2022 Nov 4;2022:5982014. doi: 10.1155/2022/5982014. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36388169 Free PMC article.
-
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters.J Enzyme Inhib Med Chem. 2021 Dec;36(1):286-294. doi: 10.1080/14756366.2020.1862103. J Enzyme Inhib Med Chem. 2021. PMID: 33334192 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
